Across TCGA pan-cancer cohorts, LILRP1 RNA is linked to patient survival in 23 of 34 cancer types, making it the most broadly survival-associated LILRP1 data layer.
The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher LILRP1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LILRP1 expression acts as an unfavorable survival marker, although some lineages such as SKCM and READ show a favorable association.
KIRP, SKCM, and LGG are the cancer types where LILRP1 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.